Financhill
Back

Bioventus 10K Form

Buy
64

BVS
Bioventus

Last Price:
11.52
Seasonality Move:
-1.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-03-26 10K BVS/Bioventus Annual

Receive BVS News And Ratings

See the #1 stock for the next 7 days that we like better than BVS

BVS Financial Statistics

Sales & Book Value

Annual Sales: $512.35M
Cash Flow: $10.25M
Price / Cash Flow: 24.77
Annual Sales: $2.29
Price / Book: 4.94

Profitability

EPS (TTM): -0.60000
Net Income (TTM): $-39.48M
Gross Margin: $328.19M
Return on Equity: -18.97%
Return on Assets: -4.96%

Bioventus Earnings Forecast

Key Bioventus Financial Ratios

  • The Gross Profit Margin over the past 9 years for BVS is 64.06%.
  • The Selling, General & Administrative Expenses for BVS have been equal to 59.31% of Gross Profit Margin.
  • The Research & Development expenses have been 2.62% of Revenue.
  • The Interest Expense is -26.04% of Operating Income.
  • The Net Earning history of BVS is -30.49% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Bioventus Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: BVS
Website: bioventus.com

Debt

Debt-to-Equity Ratio: 2.58
Current Ratio: 1.41
Quick Ratio: 0.78

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 17.1

BVS Technical Analysis vs Fundamental Analysis

Buy
64
Bioventus (BVS) is a Buy

Is Bioventus a Buy or a Sell?

  • Bioventus stock is rated a Buy
    The current Bioventus [BVS] share price is $11.41. The Score for BVS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.